Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05919511

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Incyte Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

Conditions

Interventions

TypeNameDescription
OTHERNon-InterventionalThis is an observational study

Timeline

Start date
2023-08-01
Primary completion
2027-10-15
Completion
2027-10-15
First posted
2023-06-26
Last updated
2026-03-24

Locations

32 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05919511. Inclusion in this directory is not an endorsement.